Home › Calculator › AORT Dividend Calculator 2026
AORT Dividend DRIP Calculator 2026
7.82% YieldHealthcareArtivion, Inc. · NYSE
Price: $25.57 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When AORT pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your AORT snowball 📈
$10,000 in AORT → $501.6K in 10 years · $76.75/month
About Artivion, Inc. (AORT) — Dividend Analysis 2026
Artivion Inc. is a global company that develops, produces, and supplies medical devices and implantable human tissues. Its product range includes BioGlue, a polymer derived from bovine blood protein combined with a cross-linking agent, utilized in cardiac, vascular, neurological, and pulmonary surgical applications. The company also offers heart preservation services and the PhotoFix bovine pericardial patch, in addition to E-vita Open Plus and E-vita Open Neo devices. For the treatment of aortic vascular conditions, Artivion provides specialized stent graft systems. These include E-xtra design engineering systems for aortic vascular diseases, E-nside as an off-the-shelf solution for thoraco-abdominal disease, E-vita THORACIC 3G for endovascular repair of thoracic aortic aneurysms, E-nya for minimally invasive repair of descending aorta lesions, and the E-tegra system for abdominal aortic aneurysms. Furthermore, its offerings address peripheral and renal artery treatments with the E-ventus BX balloon-expandable stent graft and the E-liac system for aneurysmal iliac arteries and their side branches. The company's diverse portfolio extends to synthetic vascular grafts for use in open aortic and peripheral vascular surgeries, PerClot (an absorbable powdered hemostat for surgical procedures), and cardiac laser therapy products for angina management. Preservation services include CryoVein for femoral veins and CryoArtery for femoral arteries. Artivion also manufactures On-X prosthetic aortic and mitral heart valves, along with the On-X ascending aortic prosthesis. Supplementary devices feature CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures designed for mitral chordal replacement, as well as ascyrus medical dissection stents. Beyond products, the company offers pyrolytic carbon coating services to other medical device manufacturers. Artivion Inc. serves a broad client base, including physicians, hospitals, other healthcare facilities, and specialists such as cardiac, vascular, thoracic, and general surgeons. Established in 1984 and headquartered in Kennesaw, Georgia, the company adopted the name Artivion Inc. in January 2022, having previously operated as CryoLife, Inc.
Compare AORT with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full AORT DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open AORT position with:
🌍 AORT Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold AORT.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 7.82% | 5.02% | $782 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 6.65% | 3.85% | $665 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 6.26% | 3.46% | $626 / yr |
| 🇬🇧 UK ISA | 0% | 7.82% | 5.02% | $782 / yr |
| 🇬🇧 UK Taxable | 8.75% | 7.14% | 4.34% | $714 / yr |
| 🇨🇦 TFSA | 0% | 7.82% | 5.02% | $782 / yr |
| 🇨🇦 CA Taxable | 25% | 5.87% | 3.07% | $587 / yr |
| 🇦🇺 Super (pension) | 15% | 6.65% | 3.85% | $665 / yr |
| 🇦🇺 AU Taxable | 30% | 5.47% | 2.67% | $547 / yr |
| 🇩🇪 DE Taxable | 26.375% | 5.76% | 2.96% | $576 / yr |
| 🇫🇷 FR Taxable | 30% | 5.47% | 2.67% | $547 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 AORT Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 AORT Dividend Payment Schedule
AORT pays quarterly — 4 times per year. Next ex-div: TBD.
📊 AORT vs Healthcare Benchmarks
How AORT compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for AORT sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ AORT Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Sale | 2026-09-02 | 6,510 | $27.27 | $177.5K | ||
| Sale | 2026-09-03 | 1,493 | $26.02 | $38.8K | ||
| Sale | 2026-08-19 | 70,000 | $28.95 | $2.03M | ||
| Sale | 2026-08-14 | 616 | $28.55 | $17.6K | ||
| Sale | 2026-08-14 | 715 | $28.55 | $20.4K | ||
| Sale | 2026-08-12 | 977 | $28.49 | $27.8K | ||
| M-Exempt | 2026-06-11 | 30,000 | $11.03 | $330.9K | ||
| M-Exempt | 2026-06-11 | 14,001 | $18.44 | $258.2K | ||
| Sale | 2026-06-11 | 14,001 | $20.71 | $289.9K | ||
| Sale | 2026-06-11 | 30,000 | $20.69 | $620.8K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Geographic Revenue Breakdown
Where AORT earns its moneyRevenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the AORT dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Artivion, Inc. (AORT) is currently trading at $25.57, 44% below its 52-week high. The current dividend yield is 7.82% based on an annual payout of $2.00 per share.
AORT (Artivion, Inc.) — 7.82% Dividend Yield Analysis
Artivion, Inc. (AORT) is a healthcare stock currently trading at $25.57 with a dividend yield of 7.82%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (7.82%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest AORT News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.